– Suvoda introduces Advanced Drug Optimization for IRT to improve the accuracy of drug supply management in clinical trials
Greater control of drug supply management helps sponsors reduce costs and carbon footprint
PHILADELPHIA, Oct. 12, 2023/PRNewswire/ — Suvoda LLC, a global clinical trial technology company specializing in complex studies in therapeutic areas such as oncology, central nervous system (CNS), and rare diseases, announced a new Advanced Trial Optimization feature. Medications as part of its latest version of Interactive Response Technology (IRT). This new functionality offers drug clinical trial sponsors better management of drug supply, resulting in cost savings and helping companies reduce their carbon footprint.
Traditionally, drug supply strategies have been based on static quantities of initial drug shipments and stockpiles, often leading to over-ordering to ensure sufficient medication is available during a trial. Buffers, a common tool to ensure adequate medication supplies across sites, create average upper and lower limits for medication stocks across trial sites and automatically trigger medication orders if supplies reach the lower limit.
Suvoda’s advanced medication optimization feature is an innovative approach that allows medication supply managers to fine-tune their supply strategies by creating “advanced rules” that take into account enrollment variables such as participant weight, predicted screening failure rates and treatment ratios. The result is more detailed and dynamic supply forecasts, which can translate into significant cost savings. Additionally, by enabling more precise drug optimization, sponsors can reduce packaging and shipping, resulting in a better carbon footprint score in support of corporate sustainability goals.
“Suvoda’s new enhancement is an example of how we listen to our customers’ needs and provide tools that help our sponsors and partners,” said Lisa Li, director of IRT product management at Suvoda. “We heard from drug supply managers that they were concerned about the impact of drug oversupply across the entire supply chain, including raw materials, manufacturing, warehousing, shipping and packaging materials. Help study managers adjust supply can maximize trial resources and increase efficiency.”
The advanced drug optimization feature is in line with Suvoda’s mission to provide clinically focused electronic solutions that enable sponsors to monitor trials with complex drug supply management needs. Examples include trials with patient cohorts that have large variations that may affect the enrollment dose, such as pediatric trials. Other trial designs that could benefit from this functionality are those involving high-cost drugs, high screening failure rates, and large trials with numerous subjects per center.
This enhancement also reinforces Suvoda’s partnership with N-SIDE, a deep technology company that enables organizations in the clinical trials industry to make better decisions and optimize the use of critical resources. Together, Suvoda and N-SIDE offer integrated forecasting and supply chain optimization to help studies reduce drug costs and waste.
“As a Suvoda partner, we are excited about this feature. We have quantified the impact of this advanced functionality in hundreds of trials, and overall it reduces medication needs by more than 10%,” said Amaury Jeandrain, vice president of strategy, sciences. of life, by N-SIDE. “Suvoda has always been committed to innovating in drug delivery to ensure its IRT solution continues to offer sponsors the greatest possible visibility and control. And, Advanced Drug Optimization gives us more tools to help our joint customers meet their needs.” of drug delivery in ways that best support your clinical trials and organizational goals.
Learn more about Suvoda IRT for clinical trials.
About SuvodaSuvoda is a global clinical trial technology company specializing in complex and vital studies in therapeutic areas such as oncology, central nervous system (CNS), and rare diseases. Founded in 2013 by eClinical technology experts, Suvoda empowers clinical trial professionals to manage the most urgent moments in the most urgent trials through advanced software solutions delivered on a single platform. Headquartered outside of Philadelphia, Suvoda also maintains offices in Portland, OR, Barcelona, Spain, Bucharest and Iasi, Romania, and Tokyo, Japan. The company’s Net Promoter Score (NPS) consistently exceeds the technology industry average, helping the company to be selected by trial sponsors and CROs to support more than 1,000 trials in 80 countries. To learn more, visit suvoda.com and follow Suvoda on LinkedIn.
For more information contact:
Mara Conklin, (847) 340-6823mconklin@teamclarus.com
Kathy Zoeller, (312) 485-2422kathy@mattsonpr.com
Logo – https://mma.prnewswire.com/media/1759317/Suvoda_Logo.jpg
View original content: https://www.prnewswire.com/news-releases/suvoda-presenta-optimizacion-avanzada-de-medicamentos-para-irt-301952522.html
